News

| Filed under Company News

Company News: Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018

— UTI panel covers 103 diagnostic targets

— 443-patient multi-center study demonstrates overall weighted average sensitivity of 95.6% at an overall weighted average specificity of 99.3%

Curetis N.V. (the “Company” and, together with Curetis USA Inc. and Curetis GmbH, “Curetis”), a developer of next-level molecular diagnostic solutions, today announced the successful completion of clinical performance evaluation and CE-IVD marking of its novel Unyvero Application Cartridge, UTI, for the diagnosis of  severe urinary tract infections. Unyvero UTI will be launched during the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) taking place in Madrid, Spain, from April 21 to 24, 2018.

Read more…

| Filed under Company News

Company News: Prof. Ugur Sahin receives prestigious European Research Council (ERC) Advanced Grant for personalized cancer vaccines

Prof. Ugur Sahin, Managing Director Research and Science at TRON (Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz gGmbH), has been awarded one of the prestigious ERC Advanced Grants 2017 for his project ‘SUMMIT – Stepping Up mRNA Mutanome Immunotherapy’, totaling 2.5 Million Euros over 5 years. The SUMMIT project will be conducted by Prof. Sahin and his team at TRON, an internationally leading research institute in the development of personalized therapy concepts and biomarkers in the field of oncology.

Read more…

| Filed under Company News

Company News: Curetis: Novel Products and Study Data to be Presented at ECCMID 2018

— Introduction of Unyvero UTI Application Cartridge

— Update on A30 RQ Analyzer to be provided

— MGI/Curetis NGS Solution for Molecular Microbiology to be featured

Curetis N.V. (the “Company” and, together with Curetis USA Inc. and Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that the Company and its subsidiary Ares Genetics GmbH will present novel products, data, and services during this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid, Spain, from April 21 – 24, 2018. Curetis and Ares Genetics can be found at booth #79, hall 10, during the conference.

Read more…